The Polyglutamine Neurodegenerative Protein Ataxin 3 Regulates Aggresome Formation

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2005 Mar 16

PMID 15767577

Citations 85

Authors

Barrington G Burnett

Randall N Pittman

Affiliations

Soon will be listed here.

Abstract

The polyglutamine-containing neurodegenerative protein ataxin 3 (AT3) has deubiquitylating activity and binds ubiquitin chains with a preference for chains of four or more ubiquitins. Here we characterize the deubiquitylating activity of AT3 in vitro and show it trims/edits K48-linked ubiquitin chains. AT3 also edits polyubiquitylated (125)I-lysozyme and decreases its degradation by proteasomes. Cellular studies show that endogenous AT3 colocalizes with aggresomes and preaggresome particles of the misfolded cystic fibrosis transmembrane regulator (CFTR) mutant CFTRDeltaF508 and associates with histone deacetylase 6 and dynein, proteins required for aggresome formation and transport of misfolded protein. Small interfering RNA knockdown of AT3 greatly reduces aggresomes formed by CFTRDeltaF508, demonstrating a critical role of AT3 in this process. Wild-type AT3 restores aggresome formation; however, AT3 with mutations in the active site or ubiquitin interacting motifs cannot restore aggresome formation in AT3 knockdown cells. These same mutations decrease the association of AT3 and dynein. These data indicate that the deubiquitylating activity of AT3 and its ubiquitin interacting motifs as well play essential roles in CFTRDeltaF508 aggresome formation.

Citing Articles

Evolutionary model of repeat insertions in Ataxin-3 traces the origin of the polyglutamine stretch to an ancestral ubiquitin binding module.

Felicio D, Martins S, Alves G, Amorim A, Macedo-Ribeiro S, Merski M Protein Sci. 2024; 33(12):e5236.

PMID: 39589068 PMC: 11590126. DOI: 10.1002/pro.5236.

ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3.

Hernandez-Carralero E, Quinet G, Freire R Expert Rev Mol Med. 2024; 26:e19.

PMID: 39320846 PMC: 11440613. DOI: 10.1017/erm.2024.10.

Spinocerebellar Ataxia Type 3 Pathophysiology-Implications for Translational Research and Clinical Studies.

Stahl F, Evert B, Han X, Breuer P, Wullner U Int J Mol Sci. 2024; 25(7).

PMID: 38612794 PMC: 11012515. DOI: 10.3390/ijms25073984.

The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases.

Potapenko A, Davidson J, Lee A, Laird A Biochem J. 2024; 481(6):461-480.

PMID: 38497605 PMC: 11088879. DOI: 10.1042/BCJ20240017.

Nuclear receptor coactivator 6 is a critical regulator of NLRP3 inflammasome activation and gouty arthritis.

Lee K, Hong B, Lee S, Lee N, Kim S, Kim D Cell Mol Immunol. 2024; 21(3):227-244.

PMID: 38195836 PMC: 10902316. DOI: 10.1038/s41423-023-01121-x.

References

Paschal B, Vallee R . Retrograde transport by the microtubule-associated protein MAP 1C. Nature. 1987; 330(6144):181-3. DOI: 10.1038/330181a0. View

Takiyama Y, Nishizawa M, Tanaka H, Kawashima S, Sakamoto H, Karube Y . The gene for Machado-Joseph disease maps to human chromosome 14q. Nat Genet. 1993; 4(3):300-4. DOI: 10.1038/ng0793-300. View

Hafezparast M, Klocke R, Ruhrberg C, Marquardt A, Ahmad-Annuar A, Bowen S . Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science. 2003; 300(5620):808-12. DOI: 10.1126/science.1083129. View

Guterman A, Glickman M . Deubiquitinating enzymes are IN/(trinsic to proteasome function). Curr Protein Pept Sci. 2004; 5(3):201-11. DOI: 10.2174/1389203043379756. View

Kawaguchi Y, Kovacs J, McLaurin A, Vance J, Ito A, Yao T . The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell. 2003; 115(6):727-38. DOI: 10.1016/s0092-8674(03)00939-5. View

Wing S . Deubiquitinating enzymes--the importance of driving in reverse along the ubiquitin-proteasome pathway. Int J Biochem Cell Biol. 2003; 35(5):590-605. DOI: 10.1016/s1357-2725(02)00392-8. View

Li F, Macfarlan T, Pittman R, Chakravarti D . Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J Biol Chem. 2002; 277(47):45004-12. DOI: 10.1074/jbc.M205259200. View

Paulson H, Perez M, Trottier Y, Trojanowski J, Subramony S, Das S . Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 1997; 19(2):333-44. DOI: 10.1016/s0896-6273(00)80943-5. View

Wilkinson K . Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin Cell Dev Biol. 2000; 11(3):141-8. DOI: 10.1006/scdb.2000.0164. View

10.

Hirabayashi M, Inoue K, Tanaka K, Nakadate K, Ohsawa Y, Kamei Y . VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ. 2001; 8(10):977-84. DOI: 10.1038/sj.cdd.4400907. View

11.

Schmidt T, Lindenberg K, Krebs A, Schols L, Laccone F, Herms J . Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions. Ann Neurol. 2002; 51(3):302-10. DOI: 10.1002/ana.10101. View

12.

Ross C, Poirier M . Protein aggregation and neurodegenerative disease. Nat Med. 2004; 10 Suppl:S10-7. DOI: 10.1038/nm1066. View

13.

Quesada V, Diaz-Perales A, Gutierrez-Fernandez A, Garabaya C, Cal S, Lopez-Otin C . Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. Biochem Biophys Res Commun. 2004; 314(1):54-62. DOI: 10.1016/j.bbrc.2003.12.050. View

14.

Perez M, Paulson H, Pendse S, Saionz S, Bonini N, Pittman R . Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J Cell Biol. 1998; 143(6):1457-70. PMC: 2132986. DOI: 10.1083/jcb.143.6.1457. View

15.

Jarosch E, Taxis C, Volkwein C, Bordallo J, Finley D, Wolf D . Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat Cell Biol. 2002; 4(2):134-9. DOI: 10.1038/ncb746. View

16.

Seilhean D, Takahashi J, El Hachimi K, Fujigasaki H, Lebre A, Biancalana V . Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions. Acta Neuropathol. 2004; 108(1):81-7. DOI: 10.1007/s00401-004-0855-x. View

17.

Martin M, Iyadurai S, Gassman A, Gindhart Jr J, Hays T, Saxton W . Cytoplasmic dynein, the dynactin complex, and kinesin are interdependent and essential for fast axonal transport. Mol Biol Cell. 1999; 10(11):3717-28. PMC: 25669. DOI: 10.1091/mbc.10.11.3717. View

18.

Chai Y, Koppenhafer S, Shoesmith S, Perez M, Paulson H . Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet. 1999; 8(4):673-82. DOI: 10.1093/hmg/8.4.673. View

19.

Garcia-Mata R, Bebok Z, Sorscher E, Sztul E . Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera. J Cell Biol. 1999; 146(6):1239-54. PMC: 2156127. DOI: 10.1083/jcb.146.6.1239. View

20.

Chai Y, Berke S, Cohen R, Paulson H . Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. J Biol Chem. 2003; 279(5):3605-11. DOI: 10.1074/jbc.M310939200. View